初期のEGFR変異性非小細胞肺がんにおける先天性耐性に関するゲノムに関する洞察: 次世代のシーケンシングデータの包括的な分析
Hayoung Seong1,2,3, Soo Han Kim1,2, Mi-Hyun Kim1,2
1Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Cancer research and treatment
|August 29, 2025
まとめ
EGFR変異を有する早期非小細胞肺がん (NSCLC) のゲノムプロファイルは早期の異質性を示しています. 初期のEGFR変異変異アレル頻度 (VAF) の低下は,同時に発生する遺伝的変異がEGFRチロシンキナーゼ阻害剤 (TKI) に対する先天性耐性を引き起こす可能性があることを示唆する.
科学分野:
- 腫瘍学
- ゲノミクス
- 分子生物学
背景:
- 皮膚成長因子受容体 (EGFR) 変異による早期非小細胞肺がん (NSCLC) の包括的なゲノムプロファイリングは十分に確立されていません.
- EGFRチロシンキナーゼ阻害剤 (TKI) に対する耐性メカニズムを特定するために,早期のゲノム変異を理解することは極めて重要です.
研究 の 目的:
- EGFR変異性NSCLCの初期および進行段階のゲノムプロフィールを調査する.
- EGFR変異性NSCLCにおけるEGFR-TKIに対する潜在的先天性耐性メカニズムを特定する.
主な方法:
- EGFR変異性NSCLC患者160人のゲノムプロファイル (100人の初期,60人の進行) の遡及分析.
- 標的型次世代配列解析 (NGS) を用いて,同時に発生する遺伝的変異 (GA),腫瘍変異負荷 (TMB),EGFR変異変異アレル頻度 (VAF) を評価した.
主要な成果:
- 初期のNSCLCと進行したNSCLCの間で同時進行するGAの割合やTMBの中央値の有意な差異はありません.
- 初期段階のEGFR変異のVAFの中央値は,進行段階のNSCLCと比較してかなり低い (19. 3% vs. 29. 6%).
- EGFR変異のVAFは疾患の進行とともに有意に増加したが,TMBは変化しなかった.
結論:
- EGFR変異性NSCLCのゲノム異質性は,腫瘍発生の初期に現れる.
- 初期段階の疾患における低 EGFR 変異のVAFは,同時進行するGAがEGFR- TKIに対する先天性耐性を引き起こす可能性があることを示唆する.
- 初期段階のEGFR変異性NSCLCでも併用療法を検討すべきである.
関連する概念動画
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


